A series of novel guanidine derivatives were synthesized in three steps and their anti-inflammatory activities in vitro and in vivo evaluated. 2-Aminopyridin-3-ol (1) was reacted with thiophosphoryl chloride (2) to give a monochloride (3). It was further reacted with cyanamide to afford the corresponding cyanamine (4), which was subsequently reacted with different heterocyclic amines to form the title compounds (5a-l). The substituent in the guanidine function affected the potency of anti-inflammatory activity. The compounds having benzothiazole, fluorophenyl, and piperazinyl moieties enhanced the anti-inflammatory activity.
Guanidine is a ubiquitous group in natural products and plays a key role in many biological activities. 2) In peptides, guanidine, a residue of l-arginine, exists in the protonated form as guanidinium ions functioning as an efficient recognition moiety of anionic substrates such as carboxylate, phosphate and intonate functionalities.
3) A wide range of biological activities and chemical applications have been found for guanidine derivatives. These have motivated the development of many reagents for their synthesis and various methods to achieve guanylation by nucleophilic addition of an amine to a cyanamide. 4) The guanidine derivatives exhibited diverse biological and pharmacological activities such as neuronal Na + and Ca 2+ channel blockers, 5) glutamate release inhibitors, anti-ischemic agents, 6) anti-seizure agents, 7) aderenergic neuron-blocking agents, 8) human immunodeficiency virus-1 (HIV-1) protease inhibitors, 9) K + /ATP channel openers, nitric oxide (NO) synthase inhibitors, influenza neuraminidase inhibitors, 10) cardiotonic agents, 11) and histamine H 3 receptor antagonists. 12) Therefore, the guanidine functional group is an attractive pharmacophore for the development of novel drugs against tumors, hypertension, glaucoma, and inflammation. 13) We previously reported that phosphorylation of various drugs improves their biological activity. 14) This finding led us to investigate the anti-inflammatory activities of a novel series of phosphorylated guanidine derivatives. Their anti-inflammatory activities in vitro and in vivo were compared versus those of conventional anti-inflammatory drugs such as aspirin, diclofenac sodium, phenyl butazone, and flufenamic acid.
Results and Discussion
Chemistry The synthesis of new biologically ac tive substituted N′-(2-thioxo-2,3-dihydro-2λ 5 -pyrido [2,3-d] [1,3,2] oxaza phosphol-2-yl) guanidine derivatives was accomplished in straight forward manner as shown in Chart 1. To synthesize target title derivatives, the key intermediate compound 4 was achieved in two steps. First, the mono chloride interme diate, 2-chloro-2,3-dihydro-2λ 5 -pyrido [2,3-d] [1,3,2] oxaza phosphole-2-thione (3) was synthesized by reaction of 2-aminopyridin-3-ol (1) with thiophosphoryl chloride (2) in tetrahydrofuran (THF) using triethylamine (TEA) as mild base by stirring at room temperature for 3 h. The formation of monochloride 3 was ascertained by TLC eluting with a 3 : 2 mixture of ethyl acetate and hexane. After completion of the reaction, the resulting triethylamine hydrochloride (Et 3 N-HCl) was removed from the reaction mixture by filtration. The filtrate containing the monochoride 3 was used for the next step of the reaction without further purification. Second, cyanamide was added in the presence of TEA to the filtrate and stirred at 30-40°C for 2 h. After completion of the reaction, the mixture was concentrated under vacuum and the residue purified by column chromatography on silica gel (100-200 mesh) using petroleum ether-ethyl acetate (3 : 7) as elutent to obtain the P-cyanamine intermediate 4. Finally, the title compounds (5a-l) were prepared by treatment of 4 with various heterocyclic/aryl amines in the presence of TEA with stirring at 50-60°C for 2 h. All the title compounds were purified by column chromatography on silica gel (100-200 mesh) using petroleum ether-ethyl acetate (2 : 3) as eluent; the title compounds were obtained in excellent yields (71-88%).
The intermediate 4 and all the title compounds were characterized by IR, H-NMR spectra exhibited peaks at δ 3.93-5.62 (br), 6.89-8.00, and 8.31-10.43 due to guanidine -NH, aromatic protons, and -C= N-H protons, respectively. 31 P-NMR chemical shifts were observed in the region −11.8 to 15.2 ppm. 15) In addition, 13 C-NMR, mass spectra, and elemental analysis provided further evidence for confirmation of the title compounds (5a-l).
Biological Evaluation. In Vitro Anti-inflammatory Activity (a) Inhibition of Albumin Denaturation: The newly synthesized compounds 5a-l were assayed for their anti-inflammatory activity with respect to inhibition of albumin denaturation. 16) In this method, the reaction mixture * To whom correspondence should be addressed. e-mail: rajuchamarthi10@gmail.com
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comprised test compounds at different concentrations and 1% aqueous solution of bovine albumin fraction. pH of the reaction mixture was adjusted to 7 using small amount of 1 n HCl. The samples were incubated at 37°C for 20 min then heated at 57°C for 20 min. After cooling the samples, the turbidity was measured spectrophotometrically at 660 nm. The experiment was performed in triplicate. Percent inhibition of protein denaturation was calculated as follows: percentage inhibition (absorbance control absorbance sample) 100 absorbance of control
Denaturation of protein is a well-documented cause of inflammation. Phenylbutazone, flufenamic acid (anti-inflammatory drugs), etc., have shown dose-dependent ability to reduce thermally induced protein denaturation. As part of the investigation on the mechanism of the anti-inflammatory activity, ability of extract to inhibit protein denaturation was studied.
It was effective in inhibiting heat-induced albumin denaturation at different concentrations as shown in (Table 1, Fig. 1 ). Maximum inhibition, 85.92± 1.48%, was observed at 0.8 µg/ mL. Flufenamic acid, a standard anti-inflammatory drug, showed maximum inhibition of, 85.36± 0.56% at a concentration of 0.2 µg/mL. In this bioassay 5a, 5b, 5g, and 5j compounds exhibited promising percent inhibition compared with that of standard.
Membrane Stabilization Test (a) Preparation of Red Blood Cells (RBCs) Suspension: Fresh whole human blood (10 mL) was collected and transferred to heparinized centrifuge tubes. The tubes were centrifuged at 3000 rpm for 10 min then washed three times with equal volume of normal saline. The volume of the blood was measured and reconstituted as 10% v/v suspension with normal saline.
(b) Heat-Induced Hemoloysis: The reaction mixture (2 mL) consisting of 1 mL of test drug solution and 1 mL of 10% RBCs suspension, was added to the test tube. 17) Aspirin was taken as a standard drug. All the centrifuge tubes containing reaction mixture were incubated in a water bath at 56°C for 30 min. At the end of the incubation, the tubes were cooled under tap water. The reaction mixture was centrifuged at 2500 rpm for 5 min and the absorbance of the supernatants taken at 560 nm. The experiments were performed in triplicate Chart 1 and presented as ( Table 2 , Fig. 2 ). Percent membrane stabilization activity was calculated by the following formula:
percentage inhibition (absorbance control absorbance sample) 100 absorbance of control
In Vivo Anti-inflammatory Activity (a) Acute Toxicology Studies: Acute toxicology study was performed on the hybrid compounds according to the Organisation for Economic Cooperation and Development (OECD) guidelines for Testing of Chemicals, No. 423 "Acute Oral Toxicity-Acute Toxic Class Method," adopted December 17, 2001. For compounds 5a to 5i mortalities were found at 5 mg/kg body weight (bw) during 24 h observation. The common clinical signs observed in the treated animals were dullness, piloerection and recumbency with 5a to 5l compounds 50 mg/kg bw treated animals during first 4 h the of observation. Abnormalities were not detected during the observation of gross pathology for all the animals.
(b) Anti-inflammatory Studies: In vivo anti-inflammatory activity was performed by carrageenan-induced paw edema and cotton pellet-induced granuloma models. Doses were selected based on the acute toxicity studies.
(c) Carrageenan Induced Paw Oedema: The test was conducted to determine the anti-inflammatory activity of the hybrid compounds.
18) The animals were pretreated with hybrid compounds or diclofenac sodium 1 h before carrageenan injection. The animals were injected with 100 µL of 1% carrageenan (0.5% carboxymethyl cellulose (CMC)) solution into the sub-plantar region of right hind paw. Paw volume was measured by dislocation of the water column in a plethysmometer after carrageenan application at 0, 1, 3, 6 and 12 h after test compound stimulus. Reduction in the paw volume compared with the vehicle-treated (0.5% CMC) control animals was considered as anti-inflammatory response; the results are shown in (Table 3 , Fig. 3 ).
(d) Cotton Pellet-Induced Granuloma: The test was performed on Wistar rats using cotton pellet-induced granuloma method. 19) The rats were anesthetized under light ether and an incision was made on the lumbar region by curved scissors; a subcutaneous tunnel was made and a sterilized cotton pellet (100± 1 mg) inserted with blunted forceps in that area. All the animals received either hybrid compounds, diclofenac sodium or vehicle (0.5% CMC) orally depending on their respective grouping for 7 d consecutively from the day of cotton pellet insertion. On day 8, animals were anesthetized again and cotton pellets removed, dried, and weighed. The results are shown in (Table 4 , Fig. 4) .
Statistical Analysis Statistical analysis was performed Graph Pad InStat version 3.0 for Windows 95, Graph Pad Software, San Diego, CA, U.S.A. The anti-inflammatory activity by membrane stabilization (in vitro), paw edema, cotton pellet (in vivo) and percent inhibition of albumin denaturation, was compared versus negative control group by one-way analysis of variance (ANOVA) with Dunnett's post-test; a value of p<0.05 was considered significant. 
Conclusion
Synthesis of novel phosphorylated guanidine derivatives containing various bioactive amines as substitutents in the guanidine function was accomplished in high yields. Based on the data obtained from the carrageenan-induced paw edema and cotton pellet-induced granuloma, all the title compounds showed good to excellent anti-inflammatory activity compared with control (diclofenac). In particular, compounds 5a, 5b, 5g, and 5j showed potent anti-inflammatory activity in in vitro and in vivo models. This enhanced activity may be due to the presence of benzothiazole, chlorobenzothiazole, fluoro-chlorophenyl, and fluorophenylpiperazinyl substituents in the guanidine function. Selected compounds of the present series will be further optimized in vitro and in vivo and investigated to explore the pharmacological mechanism of anti-inflammatory activity.
Experimental
Chemistry Chemicals were purchased from SigmaAldrich, Merck, and Lancaster, and were used without further purification. All solvents used for spectroscopic and other physical studies were reagent grade and were further purified by literature methods. 20) IR spectra were recorded as KBr pellets on a Perkin Elmer 283 unit. 86 (7H, m, Ar-H), 4.72 (1H, s, Ar′-NH 
